Quarterly report · Q2
6894.TEDINET S100S6OK
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥993m | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥69m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥94m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥88m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥333m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥120m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥112m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥119m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥76m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥243m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥82m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥76m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥82m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥4.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥4.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥105m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥191m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥40m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥24m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥19m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥140m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥226m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥130m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥55.77 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.63 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.53 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.11 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.99 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥332m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥332m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥9m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥345m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥345m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥103m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥317m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥317m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥110m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥993m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥222m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥556m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥556m |
| jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥48m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥335m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥335m |
| jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥288m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥288m |
| jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥84m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥234m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 430
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net ope cf | CurrentYTDDuration | -23007000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | -113909000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 165660000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 2140000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 2763000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -274000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -129000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -78770000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | 5743000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | -190813000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 174038000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -19292000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -36369000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | 77416000 | JPY |
| Other net inv cf | Prior1YTDDuration | -29000 | JPY |
| Other net inv cf | CurrentYTDDuration | -978000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -19322000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | 40068000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -15968000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -45160000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -76000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -110000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -114216000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -94354000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -130260000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -139625000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 12668000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 9707000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -327727000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 84189000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2212632000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1911128000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1884904000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1995317000 | JPY |
| Payroll and allowances sga | Prior1YTDDuration | 100301000 | JPY |
| Payroll and allowances sga | CurrentYTDDuration | 93650000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 21813000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 14966000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 6230000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 6172000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 287754000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | 556255000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | 334690000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1178700000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember | 287754000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |